Liver transplantation improves erectile function in patients with end-stage liver disease: a systematic review and meta-analysis

Yangyang Mei,Xiaogang Wang,Yangmeina Li,Renfang Xu,Xingliang Feng

DOI: https://doi.org/10.21037/tau-24-185

2024-10-01

Translational Andrology and Urology

Abstract:Keywords: Liver transplantation (LT); erectile dysfunction (ED); meta-analysis

urology & nephrology,andrology

What problem does this paper attempt to address?

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Sunbin Ling,Guangjiang Jiang,Qingyang Que,Shengjun Xu,Junli Chen,Xiao Xu

DOI: https://doi.org/10.1111/liv.15288

IF: 8.754

2022-01-01

Liver International

Abstract:Liver transplantation (LT) is the only effective method of treating end-stage liver disease, such as various types of liver failure. China has the largest number of patients with hepatitis B virus-related disease, which is also the main cause of liver failure. From the first LT performed in 1977, and especially over the past two decades, LT has experienced rapid development as a result of continuous research and innovation in China. China performs the second-highest number of LTs every year worldwide, and the quality of LT continues to improve. Starting January 1, 2015, all donor's livers have been from deceased donors and familial donors. Thus, China entered into a new era of LT. However, LT is still a challenging procedure in China. In this review, we introduced the brief history of LT in China, the epidemiology, aetiology and clinical outcomes of LT for liver failure in China and summarized the experience of LT from Chinese LT surgeons and scholars. The future perspectives of LT were also discussed, and it is expected that China's LT research could be further integrated elsewhere in the world.
Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients

Renyi Su,Xuyong Wei,Qiang Wei,Di Lu,Zuyuan Lin,Shuo Wang,Chuxiao Shao,Xiao Xu

DOI: https://doi.org/10.21037/hbsn-20-568

2022-01-01

HepatoBiliary Surgery and Nutrition

Abstract:Background and Objective: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients who undergo liver transplantation (LT). Whereas there is huge data on NAFLD, little is known about NAFLD in LT. In this review, we aim to explore extrahepatic organs and their potential mechanisms in the development of NAFLD in LT patients and discuss current limitations in preclinical and clinical scenarios with suggestions for future study. Methods: The following keywords, such as NAFLD, NASH, liver transplant, therapy, pathogenesis and biomarkers, were set for literature retrieval. The articles which were published articles in English till 25th June 2020 in PubMed database were included, and there is no limit for the study design type. Key Content and Findings: Following LT, there are significant shifts in the microbiota and farnesoid X receptor may be a potential therapeutic target for NAFLD in LT settings. The roles of probiotics and diet on NALFD remain inconclusive in LT background. Nevertheless, the adipokines and cytokines disorder and local insulin resistance of adipose tissue may contribute to NAFLD process. Bariatric surgeries are promising in controlling de novo and recurrent NAFLD with significant reduction in abdominal adipose tissue, despite the optimal timing is inconclusive in LT cases. Furthermore, circumstantial evidence indicates that miRNA33a may function as a mediator bridging sarcopenia and NAFLD of post-LT. beta-Hydroxy-beta-Methyl-Butyrate treatment could improve muscle status in graft recipients and shows protective potential for NAFLD in LT settings. Conclusions: Gut, adipose tissue and muscle are intricately intertwined in promoting NAFLD in LT cases. Further animal studies are needed to deepen our understanding of mechanisms in multi-organ crosstalk. High quality clinical trials are warrant for making guidelines and developing management strategies on NAFLD after LT.
Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Chenjiao Wu,Chao Lu,Chengfu Xu

DOI: https://doi.org/10.1097/MD.0000000000012026

IF: 1.6

2018-01-01

Medicine

Abstract:Background: The aim of this study was to perform a systemic review of the studies addressing the use of moderately and severely steatotic donor livers for liver transplantation. Methods: We searched the following electronic databases from January 1, 1989, to August 1, 2017: PubMed, EMBASE, Science Citation Index Expanded, and the Cochrane Library. In addition, reference lists were scanned to identify any additional reports. The quality of published papers was assessed. The main outcomes of the use of moderately and severely steatotic donor livers for liver transplantation, including primary nonfunction, short-term mortality, and long-term mortality, were extracted for pooled analysis. Results: Literature searches identified 16 studies that met the inclusion criteria. There were no randomized controlled studies, and all of the studies were retrospective or prospective case series. From a total of 3226 subjects (532 moderately and severely steatotic donor livers and 2694 controls), we found a significant increase in primary nonfunction [odds ratio (OR): 2.47, 95% confidence interval (95% CI): 1.44-4.27], and a trend of increase in 1-month patient mortality (OR: 1.90, 95% CI: 0.98-3.71) with the use of moderately and severely steatotic donor livers, whereas the 1-year mortality was relatively less influenced. Conclusion: The use of moderately and severely steatotic livers is associated with unfavorable short-term outcomes, but long-term outcomes are relatively less influenced.
Extrahepatic Organs in the Development of Non-Alcoholic Fatty Liver Disease in Liver Transplant Patients.

Renyi Su,Xuyong Wei,Qiang Wei,Di Lü,Zuyuan Lin,Shuo Wang,Chuxiao Shao,Xiao Xu

DOI: https://doi.org/10.21037/hbsn-20-568

2022-01-01

HepatoBiliary Surgery and Nutrition

Abstract:Background and Objective Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients who undergo liver transplantation (LT). Whereas there is huge data on NAFLD, little is known about NAFLD in LT. In this review, we aim to explore extrahepatic organs and their potential mechanisms in the development of NAFLD in LT patients and discuss current limitations in preclinical and clinical scenarios with suggestions for future study. Methods The following keywords, such as NAFLD, NASH, liver transplant, therapy, pathogenesis and biomarkers, were set for literature retrieval. The articles which were published articles in English till 25th June 2020 in PubMed database were included, and there is no limit for the study design type. Key Content and Findings Following LT, there are significant shifts in the microbiota and farnesoid X receptor may be a potential therapeutic target for NAFLD in LT settings. The roles of probiotics and diet on NALFD remain inconclusive in LT background. Nevertheless, the adipokines and cytokines disorder and local insulin resistance of adipose tissue may contribute to NAFLD process. Bariatric surgeries are promising in controlling de novo and recurrent NAFLD with significant reduction in abdominal adipose tissue, despite the optimal timing is inconclusive in LT cases. Furthermore, circumstantial evidence indicates that miRNA-33a may function as a mediator bridging sarcopenia and NAFLD of post-LT. β-Hydroxy-β-Methyl-Butyrate treatment could improve muscle status in graft recipients and shows protective potential for NAFLD in LT settings. Conclusions Gut, adipose tissue and muscle are intricately intertwined in promoting NAFLD in LT cases. Further animal studies are needed to deepen our understanding of mechanisms in multi-organ crosstalk. High quality clinical trials are warrant for making guidelines and developing management strategies on NAFLD after LT.
Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Guanrong Chen,Xin Hu,Yingchen Huang,Xiaonan Xiang,Sheng Pan,Ronggao Chen,Xiao Xu

DOI: https://doi.org/10.1002/mco2.444

2023-01-01

MedComm

Abstract:Liver transplantation (LT) stands as the gold standard for treating end-stage liver disease and hepatocellular carcinoma, yet postoperative complications continue to impact survival rates. The liver's unique immune system, governed by a microenvironment of diverse immune cells, is disrupted during processes like ischemia-reperfusion injury posttransplantation, leading to immune imbalance, inflammation, and subsequent complications. In the posttransplantation period, immune cells within the liver collaboratively foster a tolerant environment, crucial for immune tolerance and liver regeneration. While clinical trials exploring cell therapy for LT complications exist, a comprehensive summary is lacking. This review provides an insight into the intricacies of the liver's immune microenvironment, with a specific focus on macrophages and T cells as primary immune players. Delving into the immunological dynamics at different stages of LT, we explore the disruptions after LT and subsequent immune responses. Focusing on immune cell targeting for treating liver transplant complications, we provide a comprehensive summary of ongoing clinical trials in this domain, especially cell therapies. Furthermore, we offer innovative treatment strategies that leverage the opportunities and prospects identified in the therapeutic landscape. This review seeks to advance our understanding of LT immunology and steer the development of precise therapies for postoperative complications.
Role of the Portal System in Liver Regeneration: from Molecular Mechanisms to Clinical Management

Hanzhi Xu,Xun Qiu,Zhoucheng Wang,Kai Wang,Yawen Tan,Fengqiang Gao,Marcos Vinicius Perini,Xiao Xu

DOI: https://doi.org/10.1016/j.livres.2024.01.002

2024-01-01

Liver Research

Abstract:The liver has a strong regenerative capacity that ensures patient recovery after hepatectomy and liver transplantation. The portal system plays a crucial role in the dual blood supply to the liver, making it a significant factor in hepatic function. Several surgical strategies, such as portal vein ligation, associating liver partition and portal vein ligation for staged hepatectomy, and dual vein embolization, have highlighted the portal system’s importance in liver regeneration. Following hepatectomy or liver transplantation, the hemodynamic properties of the portal system change dramatically, triggering regeneration via shear stress and the induction of hypoxia. However, excessive portal hyperperfusion can harm the liver and negatively affect patient outcomes. Furthermore, as the importance of the gut–liver axis has gradually been revealed, the effect of metabolites and cytokines from gut microbes carried by portal blood on liver regeneration has been acknowledged. From these perspectives, this review outlines the molecular mechanisms of the portal system’s role in liver regeneration and summarizes therapeutic strategies based on the portal system intervention to promote liver regeneration.
Navigating Immune Cell Immunometabolism after Liver Transplantation

Wenhui Zhang,Zhikun Liu,Xiao Xu

DOI: https://doi.org/10.1016/j.critrevonc.2021.103227

IF: 6.625

2021-01-01

Critical Reviews in Oncology/Hematology

Abstract:Liver transplantation (LT) is the most effective treatment for end-stage liver diseases. The immunometabolism microenvironment undergoes massive changes at the interface of immune functionalities and metabolic regulations after LT. These changes considerably modify post-transplant complications, and immune cells play an influential role in the hepatic immunometabolism microenvironment after LT. Therefore, adequate studies on the complex pathobiology of immune cells are critical to prevent post-transplant complications, and the interplay between cellular metabolism and immune function is evident. Furthermore, immune cells perform their specified functions, such as activation or differentiation, accompanied by alterations in metabolic pathways, such as metabolic reprogramming. This transformation remarkably affects post-transplant complications like rejection. By targeting different metabolic pathways, regulations of metabolism are employed to shape immune responses. These differences of metabolic pathways allow for selective regulation of immune responses to further develop effective therapies that prevent graft loss after LT. This review examines immune cells in the hepatic immunometabolism microenvironment after LT, summarizes possible mechanisms and potential prevention on rejection to acquire immune tolerance, and offers some insight into references for scientific research along with clinical treatment.
Efficacy of conversion therapy on future liver remnant hypertrophy for initially unresectable colorectal liver metastases: a review of current status and perspectives

Kailin Yu,Jianwei Wang,Shuyou Peng

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2018.12.017

2018-01-01

Abstract:Surgical resection is the only effectively curative option for patients with colorectal liver metastases (CRLM).However,fewer than 20％ of those patients are deemed eligible for surgery when they were initially diagnosed.Conversion therapy,mainly used by chemotherapy,increases the opportunities of surgical treatment for patients with initially unresectable CRLM.Notably,sufficient future liver remnant (FLR)is a key factor for liver resection.The deficiency of FLR could lead to serious complications including postoperative liver failure.Surgical methods,represented by portal vein embolization (PVE),portal vein ligation (PVL) and associating liver partition and portal vein ligation for staged hepatectomy (ALPPS),could increase FLR and subsequently further increase the surgical security for CRLM patients.Most CRLM patients accept systemic chemotherapy before surgery.With extensive research has revealed the chemotherapy-induced liver injury,more attention has been shifted to explore the influence of different chemotherapy regimens,chemotherapy cycles and timing of surgery on the volume of FLR.With this review,we overview the research status of conversion therapy for initial unresectable CELM and the influence of chemotherapy on the volume of FLR.
[Erectile Function in Male Kidney Transplant Recipients and Effects of Different Methods of Renal Arterial Anastomosis].

Tao Peng,Gu-tian Zhang,Ming Chen,Shu-qiu Chen,Ze-yu Sun

DOI: https://doi.org/10.3969/j.issn.1009-3591.2007.05.003

2007-01-01

Abstract:OBJECTIVETo evaluate erectile function in men with renal failure before and after kidney transplantation and the effects of different methods of renal arterial anastomosis.METHODSFifty-five married males, aged 22-50 years, who had received kidney transplantation at least one year before and whose serum creatinine was under 200 micromol/L , were selected in the study. The end-to-end revascularization to the internal iliac artery was accomplished in 39 of them, and the end-to-side revascularization to the external iliac artery was conducted in 16. Their erectile function was investigated according to the International Index of Erectile Function-5 (IIEF-5) before kidney transplantation and 3, 6 and 9 months after it. The effects of different methods of renal arterial anastomosis were evaluated and hypophyseal hormones determined in 25 of them.RESULTSIIEF-5 was higher in the patients 3, 6 and 9 months after transplantation than before it (P < 0.05) and 6 and 9 months after transplantation than 3 months after it (P < 0.05) , so was it in the patients with less than 12 months hemodialysis than those with over 12 months (P < 0.05) and in the patients with end-to-side revascularization to the external iliac artery than those with end-to-end revascularization to the internal iliac artery (P < 0.05). The differences between the level of hypophyseal hormones and that of sex hormones before transplantation were significant (P < 0.05).CONCLUSIONErectile function and the level of hypophyseal hormones were improved after kidney transplantation, and the patients who received end-to-side revascularization to the external iliac artery experienced better erectile function recovery than those who underwent end-to-end revascularization to the internal iliac artery.
Therapeutic Effectiveness of Liver Transplantation: a Single Center Study of 203 Consecutive Cases

Jian Zhou,Jia Fan,Zhi-quan Wu,Shuang-jian Qiu,Zheng Wang,Xiao-wu Huang,Yao Yu,Yi-feng He,Zhao-you Tang,Yu-qi Wang

DOI: https://doi.org/10.3760/j:issn:0376-2491.2005.26.003

2005-01-01

Abstract:OBJECTIVE:To investigate the measures to further improve the therapeutic efficacy of liver transplantation.METHODS:The clinical data of 203 consecutive cases of orthotopic liver transplantation (OLT) performed in Zhongshan Hospital, Fudan University April 2001 to October 2004, with the indications for considering OLT of hepatocellular carcinoma (HCC) (142 cases), liver cirrhosis (36 cases), fulminant hepatic failure (7 cases), Wilson's disease (6 cases), and other end-stage liver diseases (12 cases), including 199 cases of cadaveric OLT, inclusive of 2 cases of reduced-size and 1 case of splitting liver transplantation, and 4 cases of living-donor liver transplantation, were retrospectively analyzed. Multivariate analysis using Cox proportional hazards regression model was applied to determine the risk factors predicting liver transplantation prognosis for HCC.RESULTS:For the whole group of the 201 patients, the 1-year and 2-year cumulative survival rates were 85.0% and 82.4% respectively and the rejection rate was 12.3%. In the HCC group the 1- and 2-year cumulative survival rates were 80.2% and 78.4%, and the 1- and 2-year disease-free survival (DFS) rates were 85.3% and 80.3% respectively. HCC recurrence was observed in 20 patients after OLT with a recurrence rate of 14.1%. Multivariate analysis revealed that the tumor size and portal vein tumor thrombus were the most independent and statistically significant factors affecting the DFS.CONCLUSION:OLT may be the most effective treatment option for patients with end-stage liver diseases and may also provide the opportunity of curative treatment or survival improvement for selected patients with hepatic malignancies.
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis

Tulio Caldonazo,Hristo Kirov,Panagiotis Tasoudis,Marcus Franz,Markus Richter,Murat Mukharyamov,Alexander Zipprich,Ahmad Shana'ah,Diyar Haji,Torsten Doenst

DOI: https://doi.org/10.1186/s12872-024-04252-9

2024-10-21

Abstract:Background: Liver dysfunction is a known risk factor in the cardiovascular field. It specifically increases perioperative risk in patients undergoing coronary bypass surgery. Since percutaneous coronary intervention (PCI) is the much less invasive procedure for the treatment of coronary artery disease, we aimed to assess the relationship of liver dysfunction with outcomes in patients undergoing PCI. Methods: Three libraries were searched (MEDLINE, Web of Science and The Cochrane Library). We performed a meta-analysis of all studies in patients who underwent PCI that provided information on the presence or absence of liver dysfunction. Primary outcome was short-term mortality. Secondary outcomes were major adverse cardio- and cerebrovascular events (MACCE), bleeding and acute kidney injury. Random-effects model was applied. Results: Five studies were selected and the data from 10,710,317 patients were included in the final analysis. In comparison with the absence of liver dysfunction, patients with liver dysfunction were associated with higher short-term mortality (OR 2.97, 95%CI 1.23-7.18, p = 0.02), higher MACCE (OR 1.42, 95%CI 1.08-1.87, p = 0.01), and higher bleeding (OR 2.23, 95%CI 1.65-3.00, p < 0.01). There was no significant difference regarding acute kidney injury (OR 1.20, 95%CI 0.50-2.87, p = 0.69). Conclusions: The analysis suggests that liver dysfunction in patients undergoing PCI is independently associated with higher risk of short-term mortality and increased occurrence of MACCE and bleeding. However, there appears to be no association to acute kidney injury.
Liver Transplantation for the Cure of Neuroendocrine Liver Metastasis: A Systematic Review with Particular Attention to the Risk Factors of Death and Recurrence

Quirino Lai,Alessandro Coppola,Anna Mrzljak,Maja Cigrovski Berkovic

DOI: https://doi.org/10.3390/biomedicines12112419

IF: 4.757

2024-10-23

Biomedicines

Abstract:Background/Objectives: Neuroendocrine neoplasms (NEN) are heterogeneous entities. Despite considerable advancement in the field, almost 50% of patients have metastatic disease, when liver transplantation (LT) is one of the possible treatments offering a cure in well-selected patients. Methods: The present study aims to systematically review all the literature from 2000 onwards on using LT for patients with NEN-LM, with particular attention to the risk factors of death and recurrence. Results: LT offers 5-year OS ranging from 52 to 74% and 5-year TFS rates ranging from 39 to 62%, with even better results published from 2009 onwards. The main risk factors for patient deaths are related to unfavorable primary tumor pathology, higher liver involvement, and simultaneous LT and primary resection. Similarly, recurrence is higher related to poor tumor grade and differentiation, and in the case of an older recipient age. Conclusions: Applying uniform criteria and a more in-depth understanding of the relevant prognostic factors contribute to a better selection of candidates for curative LT due to NEN metastases. LT for unresectable or liver-restricted NENs has a relevant place in the treatment algorithm and has achieved excellent results in recent decades, but more international efforts are needed to further improve outcomes.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
[Clinical Evaluation of Emergency Liver Transplantation for Patients with Benign End-Stage Liver Diseases].

Wei-lin Wang,Shu-sen Zheng,Xiao Xu,Ting-bo Liang,Jing Jin,Yan Shen,Min Zhang,Jian Wu

DOI: https://doi.org/10.3760/j:issn:0376-2491.2005.49.002

2005-01-01

Abstract:OBJECTIVE:To evaluate the efficacy of emergency liver transplantation in treating patients with benign end-stage liver diseases and explore the possible prognostic factors.METHOD:The clinic data of 46 cases of recipients who underwent ELT were retrospectively analyzed. clinicopathological variables (including age, gender, etiology, serum creatinine, PT, INR, albumin, total bilirubin) were compared between the survival group (n = 32) and the dead group (n = 14). And the prognostic values of CTP and MELD score were analyzed.RESULTS:Higher serum creatinine level, MELD score and CTP score were found in the dead group, as compared to those in survival group. The survival rates among CTP or MELD categories showed significant difference. Three-and six months and one year survival rates of total recipients were 73.9% , 71.7% and 69.6% respectively.CONCLUSION:Emergency liver transplantation is an effective treatment to salvage patients in end-stage. Serum creatinine is the important prognostic factor to the posttransplant survival. MELD score system is more sensitive than CTP classification in predicting the prognosis.
An Overview of Liver Transplantation: Current Status, Recent Techniques, and Challenges-Perspectives From a Center in China.

Zhihong Zheng,Lijin Zhao

DOI: https://doi.org/10.6002/ect.2023.0342

2024-02-01

Experimental and Clinical Transplantation

Abstract:Liver transplantation is the best way to treat end-stage liver disease.With benefits from enhanced techniques, refined management, and advanced medications, liver transplant boasts a commendable 5-year survival rate for recipients. Nevertheless, acquiring the perioperative management and surgical skills essential for liver transplant is a time-consuming process for new surgeons. In addition, COVID-19 has also affected the field. Based on our actual situation in China, we have provided an overview of donor evaluation,recipient selection,transplant procedures, postoperative complications and management, longterm management, and pandemic strategies to guide new clinical surgeons in the field.

transplantation
Erectile dysfunction in renal transplantation recipients:Mechanisms and risk factors

QI Gui-sheng,QIU Yue,XU Ming,RONG Rui-ming

DOI: https://doi.org/10.3969/j.issn.1672-6170.2011.06.005

2011-01-01

Abstract:Erection is a coordinated physiological process that requires arousal via the central nervous system(CNS),signaling via peripheral nerves,vasodilatation within the corpus cavernosum and trapping of blood within the confines of the tunica albuginea by passive veno-occlusion.At the molecular level,the process depends on a delicate balance between vasodilators and vasorelaxors in corporal smooth muscle.Various chemical signals,e.g.testosterone,noradrenaline,nitric oxide(NO),endothelin,prostaglandin-E1(PGE-1) and others,are involved in sexual function and dysfunction.Systemic or local compromise of this system at any level can lead to the development of erectile dysfunction(ED),which is defined as the inability to achieve or maintain a sufficient erection for satisfactory sexual performance.End-stage renal disease(ESRD) has been reported to cause wide-ranging disturbances of male erectile function.The underlying pathophysiological mechanisms of ED associated with ESRD have been attributed to many factors,including biochemical,endocrinological,vasculogenic,psychiatric,neurogenic,haematological and pharmacological factors[1].Kidney transplantation(KT) has become a widely used therapy for ESRD.With improving therapies and procedures,the total number of transplants has increased.Despite the medical advances enabling this success,the ability of KT to restore erectile function is still a problem.The cause of erectile dysfunction in transplant recipients is often multifactorial,including also psychogenic,neurogenic,vasculogenic and endocrine factors[4].The purpose of this article is to review the possible mechanisms and risk factors of ED after KT.
Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer: A Systematic Review and Meta-Analysis

Rebecca Varley,Munir Tarazi,Madhav Davé,Shahd Mobarak,Martyn C Stott,Minas Baltatzis,Thomas Satyadas

DOI: https://doi.org/10.1007/s00268-021-06248-4

Abstract:Backgrounds: Colorectal liver metastases were historically considered a contraindication to liver transplantation, but dismal outcomes for those with metastatic colorectal cancer and advancements in liver transplantation (LT) have led to a renewed interest in the topic. We aim to compare the current evidence for liver transplantation for non-resectable colorectal liver metastases (NRCLM) with the current standard treatment of palliative chemotherapy. Methods: A systematic review and meta-analysis of proportions was conducted following screening of MEDLINE, EMBASE, SCOPUS and CENTRAL for studies reporting liver transplantation for colorectal liver metastases. Post-operative outcomes measured included one-, three- and five-year survival, overall survival, disease-free survival and complication rate. Results: Three non-randomised studies met the inclusion criteria, reporting a total of 48 patients receiving LT for NRCLM. Survival at one-, three- and five-years was 83.3-100%, 58.3-80% and 50-80%, respectively, with no significant difference detected (p = 0.22, p = 0.48, p = 0.26). Disease-free survival was 35-56% with the most common site of recurrence being lung. Thirteen out of fourteen deaths were due to disease recurrence. Conclusion: Although current evidence suggests a survival benefit conferred by LT in NRCLM compared to palliative chemotherapy, the ethical implications of organ availability and allocation demand rigorous justification. Concomitant improvements in the management of patients following liver resection and of palliative chemotherapy regimens is paramount.
[Erectile function of renal failure patients after hemodialysis or kidney transplantation: A comparative study]

Zu-Heng Wang,Zhe Liu,Xiao-Dong Zhao,Yu-Hao Chen,Yu-Feng Gu,Dong-Rui Cheng,Jie Dong,Jian-Ping DA,Song Xu

Abstract:Objective: To study the changes in the erectile function of the male patients with renal failure after hemodialysis (HD) or kidney transplantation (KT) and explore the causes of these changes. Methods: From January 2015 to January 2021, 160 male patients with renal failure complaining of ED underwent HD (n = 80) or KT (n = 80) in the General Hospital of Eastern Theater Command. The patients were aged 25－45 (31.7 ± 4.8) years, 32 ± 4.5 years in the HD group and 31.4 ± 5.1 years in the KT group. We recorded the levels of serum T, E2, FSH and LH and the scores on IIEF-5, Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) of the patients, and compared them between the two groups. Results: Compared with the patients in the HD group, those in the KT group showed a significantly higher T level (［7.45 ± 3.54］ vs ［17.75 ± 7.32］ nmol/L, P < 0.01) and a lower E2 level (［151.37 ± 20.89］ vs ［94.17 ± 40.79］ pmol/L, P < 0.01), but no statistically significant difference from the former group in the levels of FSH (［8.12 ± 5.12］ vs ［8.97 ± 2.36］ IU/L, P > 0.05) and LH (［5.16 ± 3.87］ vs ［4.69 ± 2.18］ IU/L, P > 0.05). There were fewer cases of severe ED in the KT than in the HD group (3.75% vs 16.25%, P < 0.05). Different degrees of anxiety and depression were observed in both groups, with fewer severe cases of anxiety (6.25% vs 30.00%, P < 0.05) and depression (6.25% vs 31.25%, P < 0.05) and more mild cases of anxiety (68.75% vs 47.50%, P < 0.05) and depression (70.00% vs 48.75%, P < 0.05) in the KT than in the HD group, but no statistically significant difference in the incidence of moderate anxiety (25.00% vs 22.50%, P > 0.05) and depression (23.75% vs 20.00%, P > 0.05) between the KT and HD groups. Conclusion: For male patients with renal failure, kidney transplantation can evidently improve erectile function, while hemodialysis has a poorer effect. The altered hormone levels, anxiety and depression of the patients are important causes of the changes in their erectile function.
Design of wide temperature range resonant-mode absolute MEMS pressure sensor

G. Xereas,Charles Allan,V. Chodavarapu

DOI: https://doi.org/10.1109/NAECON.2015.7443073

2015-06-15

Abstract:We describe the design and fabrication of a resonant absolute MEMS pressure sensor using a semi-custom fabrication process. We selected a double anchored Double-Ended Tuning Fork (DETF) resonator for this work. The pressure sensor design is based on fabricating two resonant structures side by side using MEMS Integrated Design for Inertial Sensors (MIDIS) process, a commercial pure-play MEMS process recently introduced by Teledyne DALSA Semiconductor Inc. (TDSI). The fabricated devices from MIDIS process are then post-processed to etch the handle wafer below one of the resonator devices (sensor) down to a pre-determined thickness that bends in response to the external ambient pressure. The second resonator is used as the reference where the handle wafer is left untouched. The proposed differential setup enables the pressure sensor to operate over a wide temperature range from -55°C to 225°C.
Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China

Jian Chen,Zhe Yang,Fengqiang Gao,Zhisheng Zhou,Junli Chen,Di Lu,Kai Wang,Meihua Sui,Zhengxin Wang,Wenzhi Guo,Guoyue Lyu,Haizhi Qi,Jinzhen Cai,Jiayin Yang,Shusen Zheng,Xiao Xu

DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0453

2024-02-28

Abstract:Objective: Sex-specific differences are observed in various liver diseases, but the influence of sex on the outcomes of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains to be determined. This study is the first Chinese nationwide investigation of the role of sex in post-LT outcomes in patients with HCC. Methods: Data for recipients with HCC registered in the China Liver Transplant Registry between January 2015 and December 2020 were analyzed. The associations between donor, recipient, or donor-recipient transplant patterns by sex and the post-LT outcomes were studied with propensity score matching (PSM). The survival associated with different sex-based donor-recipient transplant patterns was further studied. Results: Among 3,769 patients enrolled in this study, the 1-, 3-, and 5-year overall survival (OS) rates of patients with HCC after LT were 96.1%, 86.4%, and 78.5%, respectively, in female recipients, and 95.8%, 79.0%, and 70.7%, respectively, in male recipients after PSM (P = 0.009). However, the OS was comparable between recipients with female donors and male donors. Multivariate analysis indicated that male recipient sex was a risk factor for post-LT survival (HR = 1.381, P = 0.046). Among the donor-recipient transplant patterns, the male-male donor-recipient transplant pattern was associated with the poorest post-LT survival (P < 0.05). Conclusions: Our findings highlighted that the post-LT outcomes of female recipients were significantly superior to those of male recipients, and the male-male donor-recipient transplant pattern was associated with the poorest post-LT survival. Livers from male donors may provide the most benefit to female recipients. Our results indicate that sex should be considered as a critical factor in organ allocation.

oncology,medicine, research & experimental
Efficacy And Safety Of Liver Transplantation In Patients With Cholangiocarcinoma: A Systematic Review And Meta-Analysis

Jinyang Gu,Jianling Bai,Xiaolei Shi,Jianxin Zhou,Yudong Qiu,Yafu Wu,Chunping Jiang,Xitai Sun,Fanggui Xu,Yue Zhang,Yitao Ding

DOI: https://doi.org/10.1002/ijc.26019

2012-01-01

International Journal of Cancer

Abstract:The aim of our study was to evaluate the efficacy and safety of liver transplantation in patients with cholangiocarcinoma. According to the requirements of Cochrane systematic review, a thorough literature search was performed in PubMed/Medline, Embase and Cochrane electronic databases between 1995 and 2009 in terms of the key words liver transplantation and cholangiocarcinoma, cholangiocellular carcinoma or bile duct cancer, with restricted articles for the English language. Data were processed for a meta-analysis by Stata 10 software. Altogether 14 clinical trials containing 605 transplanted patients of bile duct cancers were finally enrolled in our study. The overall 1-, 3- and 5-year pooled survival rates were 0.73 [95% confidence interval (CI) = 0.650.80], 0.42 (95% CI = 0.330.51) and 0.39 (95% CI = 0.280.51), respectively. Of note, preoperative adjuvant therapies [orthotopic liver transplantation (OLT)-PAT group] rendered the transplanted individuals with comparably favorable outcomes with 1-, 3- and 5-year pooled survival rates of 0.83 (95% CI = 0.570.98), 0.57 (95% CI = 0.180.92) and 0.65 (95% CI = 0.400.87). In addition, the overall pooled incidence of complications was 0.62 (95% CI = 0.440.78), among which that of OLT-PAT group (0.58; 95% CI = 0.200.92) was relatively acceptable compared to those of liver transplantation alone (0.61; 95% CI = 0.330.85) and liver transplantation with extended bile duct resection (0.78; 95% CI = 0.550.94). In comparison to curative resection of cholangiocarcinoma with the 5-year survival rate reported from 20 to 40%, the role of liver transplantation alone is so limited. In the future, attention will be focused on liver transplantation following neoadjuvant radiochemotherapy, which requires a well-designed, prospective randomized controlled study.

Liver transplantation improves erectile function in patients with end-stage liver disease: a systematic review and meta-analysis

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients

Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Extrahepatic Organs in the Development of Non-Alcoholic Fatty Liver Disease in Liver Transplant Patients.

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Role of the Portal System in Liver Regeneration: from Molecular Mechanisms to Clinical Management

Navigating Immune Cell Immunometabolism after Liver Transplantation

Efficacy of conversion therapy on future liver remnant hypertrophy for initially unresectable colorectal liver metastases: a review of current status and perspectives

[Erectile Function in Male Kidney Transplant Recipients and Effects of Different Methods of Renal Arterial Anastomosis].

Therapeutic Effectiveness of Liver Transplantation: a Single Center Study of 203 Consecutive Cases

Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis

Liver Transplantation for the Cure of Neuroendocrine Liver Metastasis: A Systematic Review with Particular Attention to the Risk Factors of Death and Recurrence

[Clinical Evaluation of Emergency Liver Transplantation for Patients with Benign End-Stage Liver Diseases].

An Overview of Liver Transplantation: Current Status, Recent Techniques, and Challenges-Perspectives From a Center in China.

Erectile dysfunction in renal transplantation recipients:Mechanisms and risk factors

Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer: A Systematic Review and Meta-Analysis

[Erectile function of renal failure patients after hemodialysis or kidney transplantation: A comparative study]

Design of wide temperature range resonant-mode absolute MEMS pressure sensor

Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China

Efficacy And Safety Of Liver Transplantation In Patients With Cholangiocarcinoma: A Systematic Review And Meta-Analysis